Literature DB >> 7273641

Analysis of grade 1 Hodgkin's disease (Report no 6).

M H Bennett, A Tu, G V Hudson.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7273641     DOI： 10.1016/s0009-9260(81)80174-2

Source DB:  PubMed          Journal:  Clin Radiol        ISSN： 0009-9260            Impact factor:   2.350


× No keyword cloud information.
  6 in total

1.  Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma.

Authors:  Tarsheen Sethi; Van Nguyen; Shaoying Li; David Morgan; John Greer; Nishitha Reddy
Journal:  Ther Adv Hematol       Date:  2016-10-30

2.  Hodgkin's disease: a flow cytometric study.

Authors:  K G Morgan; P Quirke; C J O'Brien; C C Bird
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

3.  Incidence and clinical importance of bone marrow eosinophilia in Hodgkin's disease (BNLI Report No 29). British National Lymphoma Investigation.

Authors:  E A Macintyre; B Vaughan Hudson; G Vaughan Hudson; A M Jelliffe; D C Linch
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

4.  Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation.

Authors:  B Vaughan Hudson; D C Linch; E A Macintyre; M H Bennett; K A MacLennan; G Vaughan Hudson; A M Jelliffe
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

Review 5.  Clinical aspects of Hodgkin's disease.

Authors:  G M Mead; J M Whitehouse
Journal:  BMJ       Date:  1988-12-17

6.  Quantity of nuclear DNA in malignancies and benign lymphadenopathies associated with Epstein-Barr virus.

Authors:  T Lehtinen; M Lehtinen; R Aine; K Dammert; P Kulomaa; M Alavaikko; P Leinikki
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.